Open in new window
|
|
Featured News
|
|
analytica Anacon India and India Lab Expo 2024 Concludes Successfully
Messe Muenchen India and the Indian Analytical Instruments Association (IAIA) organized analytica Anacon India and India Lab Expo has concluded successfully with satisfied exhibitors and delighted...
Read more
|
|
Pharmaindustrial News
|
|
Bormioli Pharma's EcoPositive Line Achieves 45 Percent Sustainable Materials Utilization
The company has made significant strides in increasing the share of sustainable materials in its products, nearing its 50 percent target by 2025 with 45 percent achieved in 2023.
Read more
|
|
|
Tetra Pharm Technologies and Glysious to Develop Transdermal Combination Drugs
Tetra Pharm Technologies has joined forces with Glysious, to develop a ground-breaking transdermal drug delivery system complementing several of Tetra Pharm Technologies' pipeline candidates.
Read more
|
|
|
Lupin Lyfe Platform Secures Class C Medical Device License from CDSCO
Lupin Digital Health has announced that its Lyfe platform has received approval as a Class C Medical Device from the Central Drugs Standard Control Organization (CDSCO).
Read more
|
|
|
PRISM BioLab and Ono Pharmaceutical Enters into Joint Research and Licensing Agreement
Under the terms of the agreement, PRISM and Ono will collaborate closely to create a development candidate for Ono's oncology target, harnessing the cutting-edge PepMetics® technology pioneered...
Read more
|
|
|
Evotec OAI Partners with Taisho Pharmaceutical to Accelerate Drug Discovery
Evotec OAI has entered into a drug discovery collaboration with Taisho Pharmaceutical Co., Ltd. Tokyo, Japan.
Read more
|
|
|
Nordic Bioproducts Group Launches its Production Facility for Advanced Cellulosic Materials
Nordic Bioproducts Group (NBG), a leader in biomaterial innovation and developer of proprietary AaltoCell Technology, has opened its commercial-scale production facility for microcrystalline cellulose...
Read more
|
|
|
USFDA Approves ImmunityBio Bladder Cancer Therapy
The United States Food and Drug Administration (USFDA) has approved ImmunityBio’s combination therapy to treat a type of bladder cancer.
Read more
|
|
Interviews
|
|
Exploring Novel and Advanced Technologies in Protein, Peptide and Biosynthetic space
Q: Could you please give us a brief overview of the Soujanya Life Sciences?
Jashan Bhumkar: Soujanya Life Sciences is a new division of our parent company...
Read more
|
|
|
|
This message and any attachments are confidential and privileged and intented for the use of the addressee only. If you have received this communication in error, please notify the sender by replay e-mail and delete this message from your system. Please note that Internet e-mail guarantees neither the confidentiality nor the proper receipt of the message sent. The data deriving from our correspondence with you are included in a file of OMNIMEDIA, S.L. which exclusive purpose is to manage the communications of the company; under the understanding that, in maintaining said correspondence, you authorize the treatment of such data for the mentioned purpose. You are entitled to exercise your rights of access, rectification, cancellation and opposition by addressing such written application to address C/ Pollensa, 2, Edif. Artemisa of. 12 de LA ROZAS (28290 - MADRID) enclosing your NIF or identifying document photocopies of.
Unsubscribe
|